Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126375691 | 12637569 | 1 | I | 20160524 | 20160809 | 20160809 | PER | US-ABBVIE-16P-163-1636559-00 | ABBVIE | 0.00 | M | Y | 54.43000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126375691 | 12637569 | 1 | PS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Unknown | AM AND PM | UNKNOWN | 18723 | 250 | MG | BID | ||||||
| 126375691 | 12637569 | 2 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | UNKNOWN | 18723 | |||||||||||
| 126375691 | 12637569 | 3 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | UNKNOWN | 18723 | |||||||||||
| 126375691 | 12637569 | 4 | SS | GENOTROPIN | SOMATROPIN | 1 | Other | PEN 12 | D029,M47802,J70854,8Q0330 | 0 | 2.5 | ML | INJECTION | QD | |||||
| 126375691 | 12637569 | 5 | SS | GENOTROPIN | SOMATROPIN | 1 | Other | PEN 12 | D029,M47802,J70854,8Q0330 | 0 | .5 | ML | INJECTION | QD | |||||
| 126375691 | 12637569 | 6 | SS | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Unknown | IN AFTERNOON | 0 | 30 | MG | QD | |||||||
| 126375691 | 12637569 | 7 | SS | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 0 | ||||||||||||
| 126375691 | 12637569 | 8 | SS | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 0 | ||||||||||||
| 126375691 | 12637569 | 9 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 1 AND HALF TABLET AM AND PM | 0 | TABLET | |||||||||
| 126375691 | 12637569 | 10 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126375691 | 12637569 | 11 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126375691 | 12637569 | 12 | SS | CLONIDINE. | CLONIDINE | 1 | Unknown | 0 | .01 | MG | TID | ||||||||
| 126375691 | 12637569 | 13 | SS | CLONIDINE. | CLONIDINE | 1 | 0 | ||||||||||||
| 126375691 | 12637569 | 14 | SS | CLONIDINE. | CLONIDINE | 1 | 0 | ||||||||||||
| 126375691 | 12637569 | 15 | SS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Unknown | AM | 0 | 75 | MG | QD | |||||||
| 126375691 | 12637569 | 16 | SS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | 0 | ||||||||||||
| 126375691 | 12637569 | 17 | SS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126375691 | 12637569 | 1 | Autism spectrum disorder |
| 126375691 | 12637569 | 2 | Tourette's disorder |
| 126375691 | 12637569 | 3 | Attention deficit/hyperactivity disorder |
| 126375691 | 12637569 | 4 | Blood growth hormone decreased |
| 126375691 | 12637569 | 6 | Autism spectrum disorder |
| 126375691 | 12637569 | 7 | Tourette's disorder |
| 126375691 | 12637569 | 8 | Attention deficit/hyperactivity disorder |
| 126375691 | 12637569 | 9 | Autism spectrum disorder |
| 126375691 | 12637569 | 10 | Tourette's disorder |
| 126375691 | 12637569 | 11 | Attention deficit/hyperactivity disorder |
| 126375691 | 12637569 | 12 | Autism spectrum disorder |
| 126375691 | 12637569 | 13 | Tourette's disorder |
| 126375691 | 12637569 | 14 | Attention deficit/hyperactivity disorder |
| 126375691 | 12637569 | 15 | Autism spectrum disorder |
| 126375691 | 12637569 | 16 | Tourette's disorder |
| 126375691 | 12637569 | 17 | Attention deficit/hyperactivity disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126375691 | 12637569 | Blood growth hormone decreased | |
| 126375691 | 12637569 | Body mass index abnormal | |
| 126375691 | 12637569 | Growth accelerated | |
| 126375691 | 12637569 | Growth retardation | |
| 126375691 | 12637569 | Malaise | |
| 126375691 | 12637569 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126375691 | 12637569 | 4 | 201506 | 201604 | 0 | |
| 126375691 | 12637569 | 5 | 201604 | 0 |